Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("HAHN RG")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 59

  • Page / 3

Export

Selection :

  • and

BLADDER CANCER TREATMENT CONSIDERATIONS FOR METASTATIC DISEASEHAHN RG.1979; SEMINARS IN ONCOL.; USA; DA. 1979; VOL. 6; NO 2; PP. 236-239; BIBL. 15 REF.Article

CLINICAL EVALUATION OF 5-(3,3-DIMETHYL-1-TRIAZENO) IMIDAZOLE-4-CARBOXAMIDE (NSC-45388), MELPHALAN (NSC-8806), AND HYDROXYUREA (NSC-32065) IN THE TREATMENT OF DISSEMINATED MALIGNANT MELANOMAAHMANN DL; HAHN RG; BISEL HF et al.1972; CANCER CHEMOTHERAPY REP., 1; U.S.A.; DA. 1972; VOL. 56; NO 3; PP. 369-372; BIBL. 7REF.Serial Issue

A COMPARATIVE STUDY OF 1-(2-CHLOROETHYL)-3-CYCLOHEXYL-1-NITROSOUREA (NSC79037) AND IMIDAZOLE CARBOXAMIDE (NSC 45388) WITH VINCRISTINE (NSC 67574) IN THE PALLIATION OF DISSEMINATED MALIGNANT MELANOMA = ETUDE COMPARATIVE DE LA CHLORO-2 ETHYL-1 CYCLOHEXYL-5 NITROSO-1 UREE (NSC79037) ET DE L'IMIDAZOLE CARBOXAMIDE (NSC45388) ASSOCIE A LA VINCRISTINE (NSC67574) DANS LE TRAITEMENT DU MELANOME MALIN DISSEMINEAHMANN DL; HAHN RG; BISEL HF et al.1972; CANCER RES.; U.S.A.; DA. 1972; VOL. 32; NO 11; PP. 2432-2434; BIBL. 5REF.Serial Issue

PHASE II STUDY OF MAYTANSINE IN ADVANCED SARCOMAS = ETUDE PHASE II DE LA MAYTANSINE DANS LES SARCOMES EVOLUESEDMONSON JH; HAHN RG; CREAGAN ET et al.1983; CANCER TREATMENT REPORTS; ISSN 0361-5960; USA; DA. 1983; VOL. 67; NO 4; PP. 401-402; BIBL. 3 REF.; GRAPHArticle

PHASE II TRIAL OF DOXORUBICIN THERAPY FOR ADVANCED ISLET CELL CARCINOMAMOERTEL CG; LAVIN PT; HAHN RG et al.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 7; PP. 1567-1569; BIBL. 2 REF.Article

PHASE II STUDY OF VINBLASTINE-CCNU, TRIAZINATE, AND DACTINOMYCIN IN ADVANCED RENAL CELL CANCERHAHN RG; BEGG CB; DAVIS T et al.1981; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1981; VOL. 65; NO 7-8; PP. 711-713; BIBL. 7 REF.Article

CARDIOPULMONARY RESUSCITATION IN A UNIVERSITY HOSPITAL. AN ANALYSIS OF SURVIVAL AND COSTHAHN RG; HUTCHINSON JC; CONTE JE JR et al.1979; WEST. J. MED.; USA; DA. 1979; VOL. 131; NO 4; PP. 344-348; BIBL. 20 REF.Article

PHASE II CLINICAL TRIAL OF ISOPHOSPHAMIDE (NSC-109724) IN PATIENTS WITH ADVANCED BREAST CANCERAHMANN DL; BISEL HF; HAHN RG et al.1974; CANCER CHEMOTHERAPY REP., 1; U.S.A.; DA. 1974; VOL. 58; NO 6; PP. 861-865; BIBL. 3 REF.Article

ADRIAMYCIN (NSC-123127) VERSUS 5-FLUOROURACIL (NSC-19893) AND CYCLOPHOSPHAMIDE (NSC-26271) IN THE TREATMENT OF METASTATIC PROSTATE CANCEREAGAN RT; HAHN RG; MYERS RP et al.1976; CANCER TREATM. REP.; U.S.A.; DA. 1976; VOL. 60; NO 1; PP. 115-117; BIBL. 5 REF.Article

DISSEMINATED BREAST CANCER: EVALUATION OF HORMONAL THERAPY UTILIZING STILBESTROL AND MEDROGESTONE (AY-62022) SINGLY AND IN COMBINATION = CANCER DU SEIN DISSEMINE: VALEUR DE LA THERAPEUTIQUE HORMONALE PAR STILBOESTROL ET MEDROGESTONE (AY-62022) SEULES OU ASSOCIEESAHMANN DL; HAHN RG; BISEL HF et al.1972; CANCER; U.S.A.; DA. 1972; VOL. 30; NO 3; PP. 651-653; BIBL. 11REF.Miscellaneous

A CLINICAL TRIAL ADRIAMYCIN (NSC 123127) IN ADVANCED SARCOMAS.CREAGAN ET; HAHN RG; AHMANN DL et al.1977; ONCOLOGY; SUISSE; DA. 1977; VOL. 34; NO 2; PP. 90-91Article

ORAL BENZAQUINAMIDE IN THE TREATMENT OF NAUSEA AND VOMITING.MOERTEL CG; SCHUTT AJ; HAHN RG et al.1975; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1975; VOL. 18; NO 5; PP. 554-557; BIBL. 6 REF.Article

PHASE II STUDY OF CHROMOMYCIN A3(NSC-58514) IN ADVANCED COLORECTAL CARCINOMA.MOERTEL CG; SCHUTT AJ; HAHN RG et al.1975; CANCER CHEMOTHERAPY REP., 1; U.S.A.; DA. 1975; VOL. 59; NO 3; PP. 577-579; BIBL. 6 REF.Article

A PHASE 2 STUDY OF INTERMITTENT HIGH DOSE ISOPHOSPHAMIDE THERAPY OF ADVANCED COLORECTAL CANCER = UNE ETUDE EN PHASE 2 DU TRAITEMENT DU CANCER COLORECTAL AVANCE PAR DE L'ISOPHOSPHAMIDE INTERMITTENT ET A HAUTES DOSESKOVACH JS; SCHUTT AJ; HAHN RG et al.1974; ONCOLOGY; SWITZ.; DA. 1974; VOL. 29; NO 1; PP. 34-39; BIBL. 4 REF.Article

PHASE II STUDY OF 5-AZACYTIDINE (NSC-102816) IN THE TREATMENT OF ADVANCED GASTROINTESTINAL CANCERMOERTEL CG; SCHUTT AJ; REITEMEIER RJ et al.1972; CANCER CHEMOTHERAPY REP., 1; U.S.A.; DA. 1972; VOL. 56; NO 5; PP. 649-652; BIBL. 6 REF.Serial Issue

TREATMENT OF THE PATIENT WITH ADENOCARCINOMA OF UNKNOWN ORIGINMOERTEL CG; REITEMEIER RJ; SCHUTT AJ et al.1972; CANCER; U.S.A.; DA. 1972; VOL. 30; NO 6; PP. 1469-1472; BIBL. 3 REF.Serial Issue

A PHASE II STUDY OF 1-(2-CHLOROETHYL)-3-CYCLOHEXYL-1-NITROSOUREA (NSC9037) IN THE PALLIATIVE MANAGEMENT OF ADVANCED GASTROINTESTINAL CANCER = PHASE II DE L'ETUDE DE LA (CHLORO-2 ETHYL)-1 CYCLOHEXYL-3 NITROSO-1 UREE (NSC79037) DANS LE TRAITEMENT PALLIATIF DU CANCER GASTRO-INTESTINAL AVANCEMOERTEL CG; SCHUTT AJ; REITEMEIER RJ et al.1972; CANCER RES.; U.S.A.; DA. 1972; VOL. 32; NO 6; PP. 1278-1279; BIBL. 3REF.Serial Issue

SURGICAL PROVEN PULMONARY METASTASES NOT DEMONSTRATED BY COMPUTED CHEST TOMOGRAPHYCREAGAN ET; FRYTAK S; PAIROLERO P et al.1978; CANCER TREATM. REP.; USA; DA. 1978; VOL. 62; NO 9; PP. 1404-1405; BIBL. 6 REF.Article

COMPARATIVE STUDY OF METHYL-CCNU(NSC-95441) WITH CYCLOPHOSPHAMIDE (NSC-26271) AND 5-(3,3 DIMETHYL-1-TRIAZENO)IMIDAZOLE-4-CARBOXAMIDE (NSC-45388) WITH VINCRISTINE (NSC-67574) IN PATIENTS WITH DISSEMINATED MALIGNANT MELANOMAAHMANN DL; HAHN RG; BISEL HF et al.1975; CANCER CHEMOTHERAPY REP.; U.S.A.; DA. 1975; VOL. 59; NO 2; PP. 451-453; BIBL. 5REF.Article

A DOUBLE-BLIND COMPARISON OF INTENSIVE COURSE 5-FLUOROURACIL BY ORALS VS. INTRAVENOUS ROUTE IN THE TREATMENT OF COLORECTAL CARCINOMAHAHN RG; MOERTEL CG; SCHUTT AJ et al.1975; CANCER; U.S.A.; DA. 1975; VOL. 35; NO 4; PP. 1031-1035; BIBL. 3 REF.Article

EVALUATION OF CYCLOPHOSPHAMIDE (NSC-26271) AND 1,3-BIS(2-CHLOROETHYL)-1-NITROSOUREA (BCNU; NSC-409962) IN THE TREATMENT OF PATIENTS WITH INOPERABLE OR DISSEMINATED LUNG CANCERAHMANN DL; CARR DT; COLES DT et al.1972; CANCER CHEMOTHERAPY REP., 1; U.S.A.; DA. 1972; VOL. 56; NO 3; PP. 401-403; BIBL. 1REF.Serial Issue

CONTROLLED EVALUATION OF ADRIAMYCIN (NSC-123127) IN PATIENTS WITH DISSEMINATED BREAST CANCERAHMANN DL; BISEL HF; EAGAN RT et al.1974; CANCER CHEMOTHERAPY REP., 1; U.S.A.; DA. 1974; VOL. 58; NO 6; PP. 877-882; BIBL. 7 REF.Article

PHASE II STUDY IN ADVANCED SARCOMA: RANDOMIZED TRIAL OF PYRAZOFURIN VERSUS COMBINATION CYCLOPHOSPHAMIDE, DOXORUBICIN, AND CIS-DICHLORODIAMMINEPLATINUM (II) (CAP)CORMIER WJ; HAHN RG; EDMONSON JH et al.1980; CANCER TREATM. REP.; USA; DA. 1980; VOL. 64; NO 4-5; PP. 655-658; BIBL. 12 REF.Article

PHASE I STUDY OF A FIVE-DAY INTERMITTENT SCHEDULE FOR 1,2: 5,6-DIANHYDROGALACTITOL (NSC-132313).EAGAN RT; MOERTEL CG; HAHN RG et al.1976; J. NATION. CANCER INST.; U.S.A.; DA. 1976; VOL. 56; NO 1; PP. 179-181; BIBL. 5 REF.Article

PHASE II STUDY OF ICRF-159 (NSC-129943) IN ADVANCED COLORECTAL CARCINOMA.MARCINIAK TA; MOERTEL CG; SCHUTT AJ et al.1975; CANCER CHEMOTHERAPY REP., 1; U.S.A.; DA. 1975; VOL. 59; NO 4; PP. 761-763; BIBL. 5 REF.Article

  • Page / 3